Drug Pipeline

Ivosidenib Oral Tablet Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05876754 An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or… Cholangiocarcinoma Recruiting
Phase 2
NCT07507760 Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients Acute Myeloid Leukemia With Gene Mutations Not Yet Recruiting
Phase 1
NCT07006688 A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic… IDH1-Mutated Malignancies Recruiting
Sponsors Running Ivosidenib Oral Tablet Trials
Servier Affaires Médicales (1) Servier Bio-Innovation LLC (1) PETHEMA Foundation (1)
Disease Areas
Cholangiocarcinoma (1) Leukemia (1) Acute Myeloid Leukemia (AML) (1)
Get alerts when Ivosidenib Oral Tablet trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free